-
-
-
-
-
-
-
Dare Bioscience (DARE) Misses Q1 EPS by 20c
-
-
-
-
-
-
-
Maxim Group Upgrades Dare Bioscience (DARE) to Buy, PT $8
-
-
-
-
-
-
-
Dare Bioscience (DARE) and Rosy Wellness Announce Strategic Collaboration to Educate and Market Daré’s DARE to PLAY Sildenafil Cream
-
-
-
-
-
-
-
Dare Bioscience (DARE) Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene Pivotal Study Clinical Trial Sites
-
-
-
-
-
-
-
Dare Bioscience (DARE) Regains Nasdaq Compliance
-
-
448,180 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

